Plan B · Case Example · Consented & de-identified
He is not unfixable. He is genuinely complicated — and, finally, legible.
Each piece had been looked at in isolation by someone. The integration is the whole point.
The picture when they came
A parent who had done years of homework and tried a remarkable list of interventions — some that clearly helped, several that made things distinctly worse. The “made it worse” list turned out to be the most informative part of the chart, because the same biochemistry explained why.
Recent history included a regression following a hands-on bodywork-type intervention, which had since stabilized — the most severe features (a flat, frozen, catatonic-leaning state) had already lifted by the time we synthesized. That mattered: it meant we were building on a stabilizing baseline, not chasing a crisis.
What we needed to answer: with this many possible drivers, what’s actually moving the needle, in what order, and what’s safe to do first in a kid who reacts badly to standard protocols?
What the data actually showed
Every finding below was read directly from the source lab reports in his file and checked against that test’s own reference range. We describe direction only — high, low, or in-range — not specific values.
This is the single biggest finding, and it had been sitting unaddressed.
- Both standard strep antibody titers were elevated on his most recent panel — and elevated across multiple prior draws over a span of years.
- Both titers elevated together and persistently is the textbook post-streptococcal immune signature (the picture behind the PANDAS/PANS framework). His earliest comparison values had been normal, so these rose over time — this is real movement, not a lifelong baseline.
This is the kind of finding that, once named, reorganizes everything downstream.
His prior practitioner’s methylation panel framed him as an undermethylator with a sulfur-pathway pattern, impaired B12 recycling, and vitamin-D-receptor variants. We hold the genomic interpretation at the practitioner’s confidence level — but it lines up cleanly with what his bloodwork shows and, crucially, with his treatment history:
- Whole-blood histamine: high — a classic undermethylator/histadelic biomarker, captured cleanly.
- Things that made him worse — NAC, binders, standard methylation supplements — are exactly what you’d predict to backfire in a high-sulfur, sensitive-responder phenotype if dosed the standard way.
The practical upshot: the reason most protocols failed was not a “try harder” problem. It was that the standard scripts were the wrong scripts for his engine.
- Strong environmental allergy — top-tier reactivity to common indoor allergens, the kind tied to allergic-asthma risk.
- Whole-blood histamine high (above). Total IgE elevated.
Environmental mitigation here (encasements, HEPA, reducing indoor allergen exposure) is low-cost and can lower his systemic histamine load without a single supplement.
- A chronic enteroviral signature: persistently elevated across panels more than a year apart, with no sign of shifting — a known PANS trigger that hasn’t moved.
- A common atypical-respiratory pathogen was antibody-positive on prior panels (including a strongly active pattern at one point) — then a long stretch with no retest.
An organic-acids panel flagged a yeast/fungal overgrowth pattern, dysbiosis markers, and elevated oxalate — the lab’s own printed read was a yeast/fungal overgrowth pattern.
This is a subtle, important one. Standard inflammation markers (hs-CRP, ESR) were normal/low — which a conventional workup would read as “not inflamed.” But his urinary neurotransmitter panel told a different story:
- Kynurenine: high (an inflammatory/“tryptophan-steal” marker).
- Depletion patterns in other neurotransmitter markers, consistent with a chronically inflamed, run-down system.
- Elevated dopamine turnover (can track with anxiety/OCD-type features).
A normal CRP did not mean a calm brain.
Just as important — what we ruled OUT
Ruling things out is how you keep a complex kid from getting over-treated:
- Tick-borne disease (Lyme and major co-infections): essentially negative across a full specialty panel and a separate blot. No tick-borne treatment indicated. (This is a real divergence from other kids in our practice — his infectious profile is genuinely different.)
- Cerebral folate deficiency: ruled out (folate-receptor antibodies negative) — which spares an unnecessary leucovorin trial.
- Copper overload: ruled out — he is, if anything, low in copper, which flips the standard undermethylator “lower the copper with zinc” script on its head.
- Thyroid autoimmunity, celiac, ANA-driven autoimmunity: all negative.
- B12 and vitamin D deficiency: ruled out (both sufficient, including the functional markers).
How it integrates
Here is the integration no single specialist had done — and it’s the whole point of the case.
- The post-strep autoimmunity is the unaddressed root. Both strep titers, high together, persistently, for years, with no treatment plan ever attached. Much of the downstream chemistry — the neuroinflammation, the histamine, the depleted neurotransmitters — is plausibly responding to a chronic immune activation that no one had named as the lead.
- His biochemistry is why “standard care” hurt instead of helped. The undermethylator phenotype with a sulfur-pathway bottleneck means the usual supplement scripts (and even binders) push into a pathway he can’t clear well. So you don’t run the standard protocol louder — you sequence it differently, start every addition at a fraction of the normal dose, change one variable at a time, and watch.
- Order matters more than ingredients. Open the clearance/exit pathways first (bowel regularity, the sulfite-clearing cofactor, gentlest B12 form), then add support, then go after the infections — so that when you mobilize something, his body can actually carry it out instead of flaring.
- The cheapest interventions are among the highest-yield. Allergen mitigation lowers histamine load for the price of mattress encasements and a filter. Naming and treating the strep is the single biggest lever and doesn’t require anything exotic.
- One real-world signal pointed straight at the gut-brain axis. A brief, uncontrolled trial of a gut-targeted immunoglobulin (a binder-type agent) produced a rough reaction followed by a genuine breakthrough — the most severe, frozen features lifted and “his real self” surfaced. Read carefully, that’s a clue that a gut-derived inflammatory/toxin burden was driving his most severe state — and a reason to build the clearance engine before re-trying it, slowly, as a single readable variable.
The reframe we gave the family
He is not unfixable. He is genuinely complicated — and, finally, legible.
What to ask & test next
Framed as questions for the family’s practitioner team — Plan B is a parent-navigator, not a prescriber.
Treat the strep — this is the headline question
- Is he carrying strep now (throat culture)? Is there a chronic-carrier or tonsil source?
- What’s the strep-treatment plan, and is he an immunomodulation (e.g. IVIG) candidate if titers don’t fall? An autoimmune-encephalitis antibody panel is worth running in parallel, because a positive result opens a different treatment door entirely.
Confirm the methylation / biotype picture before layering supplements
- Pyrrole (kryptopyrrole) testing, ceruloplasmin + % free copper (to settle the copper/zinc question — his low-copper pattern argues against the usual zinc step), fresh cellular zinc/magnesium, and methylation genotyping to ground the SNP interpretation.
Re-test the infections that haven’t been re-checked
- The atypical-respiratory pathogen (IgM + IgG + PCR) and an enteroviral repeat — to see whether the chronic viral load is moving.
Do the cheap, high-yield environmental work now
- Allergen encasements + HEPA + indoor-allergen mitigation, and a proper MCAS/histamine workup (DAO, tryptase) that’s never been run.
Fill the genuine gaps
- A urine mycotoxin panel (never done; a humid-climate home makes environmental mold exposure plausible) and a stool/GI panel (repeatedly ordered but never collected).
Sequencing rule for everything
Start at a fraction of the standard dose, one new variable at a time, with a 5–7 day watch, and a clear “if it gets worse, stop and step back” plan — because attacking/aggression reactions are real for him.
Confidence & caveats
- High confidence: the strep titers, the high whole-blood histamine, the strong allergy load, the neuroinflammatory marker pattern, the chronic enteroviral signature, and the rule-outs — all read directly from his source lab reports against each test’s own range.
- Medium confidence: the methylation/SNP interpretation. It comes from his prior practitioner’s narrative panel rather than a raw genomic report we hold, so we carry it at that practitioner’s confidence level. It’s clinically coherent and matches his treatment history — but it’s an interpretation, not an independently verified primary result.
- Medium confidence: the single-trial gut-immunoglobulin “breakthrough.” One uncontrolled trial is suggestive, not proof; the value is in what his body’s response points at, not in the agent itself.
- Dated findings are dated findings. Several findings are months to a couple of years old. They’re framed as “worth a recheck,” not as today’s truth — which is exactly why the next-step list leads with re-testing.
- This is one child. Nothing here is a protocol for anyone else. The point of sharing Max is the method — read everything, integrate across frameworks, sequence by his biology, and let the labs decide.